ResMed (RMD) Competitors

ResMed (NYSE:RMD) and Medtronic (NYSE:MDT) are both large-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, valuation, institutional ownership, community ranking, analyst recommendations, earnings, risk, profitability and media sentiment.

Does the MarketBeat Community prefer RMD or MDT?

Medtronic received 1153 more outperform votes than ResMed when rated by MarketBeat users. Likewise, 75.40% of users gave Medtronic an outperform vote while only 52.71% of users gave ResMed an outperform vote.

Company	Underperform	Outperform
ResMed	Outperform Votes 438 52.71%	Underperform Votes 393 47.29%
Medtronic	Outperform Votes 1591 75.40%	Underperform Votes 519 24.60%

Do analysts rate RMD or MDT?

ResMed presently has a consensus price target of $258.83, indicating a potential upside of 5.44%. Medtronic has a consensus price target of $96.07, indicating a potential upside of 18.70%. Given Medtronic's higher probable upside, analysts clearly believe Medtronic is more favorable than ResMed.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ResMed	1 Sell rating(s)	5 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.60
Medtronic	1 Sell rating(s)	8 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.47

Is RMD or MDT more profitable?

ResMed has a net margin of 25.34% compared to Medtronic's net margin of 12.83%. ResMed's return on equity of 26.17% beat Medtronic's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
ResMed	25.34%	26.17%	18.60%
Medtronic	12.83%	14.07%	7.70%

Do institutionals and insiders have more ownership in RMD or MDT?

55.0% of ResMed shares are held by institutional investors. Comparatively, 82.1% of Medtronic shares are held by institutional investors. 0.7% of ResMed shares are held by insiders. Comparatively, 0.2% of Medtronic shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Is RMD or MDT a better dividend stock?

ResMed pays an annual dividend of $2.12 per share and has a dividend yield of 0.9%. Medtronic pays an annual dividend of $2.80 per share and has a dividend yield of 3.5%. ResMed pays out 23.8% of its earnings in the form of a dividend. Medtronic pays out 85.1% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. ResMed has raised its dividend for 13 consecutive years and Medtronic has raised its dividend for 48 consecutive years. Medtronic is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Does the media refer more to RMD or MDT?

In the previous week, Medtronic had 26 more articles in the media than ResMed. MarketBeat recorded 68 mentions for Medtronic and 42 mentions for ResMed. ResMed's average media sentiment score of 1.22 beat Medtronic's score of 0.83 indicating that ResMed is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
ResMed	31 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Medtronic	32 Very Positive mention(s)	5 Positive mention(s)	20 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has stronger earnings & valuation, RMD or MDT?

Medtronic has higher revenue and earnings than ResMed. Medtronic is trading at a lower price-to-earnings ratio than ResMed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ResMed	$5.02B	7.17	$1.02B	$8.91	27.55
Medtronic	$33.20B	3.13	$3.68B	$3.29	24.60

Which has more risk and volatility, RMD or MDT?

ResMed has a beta of 0.78, indicating that its stock price is 22% less volatile than the S&P 500. Comparatively, Medtronic has a beta of 0.81, indicating that its stock price is 19% less volatile than the S&P 500.

Summary

ResMed beats Medtronic on 11 of the 21 factors compared between the two stocks.